Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. 2001

D S Freedman, and L K Khan, and W H Dietz, and S R Srinivasan, and G S Berenson
Division of Nutrition and Physical Activity, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. dfreedman@cdc.gov

BACKGROUND Childhood obesity is related to adult levels of lipids, lipoproteins, blood pressure, and insulin and to morbidity from coronary heart disease (CHD). However, the importance of the age at which obesity develops in these associations remains uncertain. OBJECTIVE We assessed the longitudinal relationship of childhood body mass index (BMI, kg/m(2)) to adult levels of lipids, insulin, and blood pressure among 2617 participants. All participants were initially examined at ages 2 to 17 years and were reexamined at ages 18 to 37 years; the mean follow-up was 17 years. RESULTS Of the overweight children (BMI >/=95th percentile), 77% remained obese (>/=30 kg/m(2)) as adults. Childhood overweight was related to adverse risk factor levels among adults, but associations were weak (r ~ 0.1-0.3) and were attributable to the strong persistence of weight status between childhood and adulthood. Although obese adults had adverse levels of lipids, insulin, and blood pressure, levels of these risk factors did not vary with childhood weight status or with the age (</=8 years, 12-17 years, or >/=18 years) of obesity onset. CONCLUSIONS Additional data are needed to assess the independent relationship of childhood weight status to CHD morbidity. Because normal-weight children who become obese adults have adverse risk factor levels and probably will be at increased risk for adult morbidity, our results emphasize the need for both primary and secondary prevention.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007339 Insulysin An enzyme the catalyzes the degradation of insulin, glucagon and other polypeptides. It is inhibited by bacitracin, chelating agents EDTA and 1,10-phenanthroline, and by thiol-blocking reagents such as N-ethylmaleimide, but not phosphoramidon. (Eur J Biochem 1994;223:1-5) EC 3.4.24.56. Insulinase,Insulin Protease,Insulin Proteinase,Insulin-Degrading Enzyme,Enzyme, Insulin-Degrading,Insulin Degrading Enzyme,Protease, Insulin,Proteinase, Insulin
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008145 Louisiana State bounded by Arkansas on the north, by Mississippi on the east, the Gulf of Mexico on the south and Texas on the west.
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary

Related Publications

D S Freedman, and L K Khan, and W H Dietz, and S R Srinivasan, and G S Berenson
November 2003, JAMA,
D S Freedman, and L K Khan, and W H Dietz, and S R Srinivasan, and G S Berenson
August 2014, The American journal of the medical sciences,
D S Freedman, and L K Khan, and W H Dietz, and S R Srinivasan, and G S Berenson
September 2019, Diabetes care,
D S Freedman, and L K Khan, and W H Dietz, and S R Srinivasan, and G S Berenson
December 2001, Metabolism: clinical and experimental,
D S Freedman, and L K Khan, and W H Dietz, and S R Srinivasan, and G S Berenson
January 2001, Preventive cardiology,
D S Freedman, and L K Khan, and W H Dietz, and S R Srinivasan, and G S Berenson
December 1995, The Journal of pediatrics,
D S Freedman, and L K Khan, and W H Dietz, and S R Srinivasan, and G S Berenson
November 2002, The American journal of cardiology,
D S Freedman, and L K Khan, and W H Dietz, and S R Srinivasan, and G S Berenson
January 1993, Nutrition and health,
Copied contents to your clipboard!